Ethnic differences and predictors of colonoscopy, prostate-specific antigen, and mammography screening participation in the multiethnic cohort

详细信息    查看全文

• 作者：Brook E. Harmon^a ; ^{bharmon@cc.hawaii.edu" class="auth_mail} ; Melissa A. Little^a ; Erica D. Woekel^a ; ¹ ; Reynolette Ettienne^a ; ² ; Camonia R. Long^a ; ² ; Lynne R. Wilkens^a ; Loic Le Marchand^a ; Brian E. Henderson^b ; Laurence N. Kolonel^a ; Gertraud Maskarinec^a
• 关键词：Mammogram ; PSA ; Colonoscopy ; Cancer screening ; Ethnic differences
• 刊名：Cancer Epidemiology
• 出版年：April, 2014
• 年：2014
• 卷：38
• 期：2
• 页码：162-167
• 全文大小：300 K

文摘

Purpose

Given the relation between screening and improved cancer outcomes and the persistence of ethnic disparities in cancer mortality, we explored ethnic differences in colonoscopy, prostate-specific antigen (PSA), and mammography screening in the Multiethnic Cohort Study.

Methods

Logistic regression was applied to examine the influence of ethnicity as well as demographics, lifestyle factors, comorbidities, family history of cancer, and previous screening history on self-reported screening participation collected in 1999-2002.

Results

The analysis included 140,398 participants who identified as white, African American, Native Hawaiian, Japanese American, US born-Latino, or Mexican born-Latino. The screening prevalences overall were mammography: 88% of women, PSA: 45% of men, and colonoscopy: 35% of men and women. All minority groups reported 10-40% lower screening utilization than whites, but Mexican-born Latinos and Native Hawaiian were lowest. Men were nearly twice as likely to have a colonoscopy (OR = 1.94, 95% CI = 1.89-1.99) as women. A personal screening history, presence of comorbidities, and family history of cancer predicted higher screening utilization across modalities, but to different degrees across ethnic groups.

Conclusions

This study confirms previously reported sex differences in colorectal cancer screening and ethnic disparities in screening participation. The findings suggest it may be useful to include personal screening history and family history of cancer into counseling patients about screening participation.